Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02767726 · ClinicalTrials.gov registry record · NA

A Non-Invasive Cervical Cancer Screening Modality: A Pilot Study

A NA study, sponsored by Abramson Cancer Center at Penn Medicine.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT02767726: Clinical Trial NA study, sponsored by Abramson Cancer Center at Penn Medicine.

NCT02767726 is a NA study that was terminated before completion, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02767726, a NA study, was terminated before completion, sponsored by Abramson Cancer Center at Penn Medicine.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

Cervix cancer is a major global health concern. A way to screen and immediately treat precancerous lesions (Screen-and-Treat) is greatly needed. Developed by MobileOCT, polarized difference imaging and conventional imaging are used to identify suspicious lesions. We aim to compare this non-invasive method with colposcopy. Patients at the Dickens Clinic will have 3-5 minutes of non-invasive imaging before colposcopy. Pathology will be compared both to colposcopy impression versus MobileOCT.

Interventions

  • DEVICE non-invasive multimodal imaging

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2016-01
Est. Completion 2017-04
Phase NA

Why NCT02767726 stopped before completion

NCT02767726 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which non-invasive multimodal imaging is the first listed.

NCT02767726 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02767726 about?

NCT02767726 is a clinical study titled "A Non-Invasive Cervical Cancer Screening Modality: A Pilot Study". Cervix cancer is a major global health concern. A way to screen and immediately treat precancerous lesions (Screen-and-Treat) is greatly needed. Developed by MobileOCT, polarized difference imaging and conventional imaging are used to identify suspicious lesions. We aim to compare this non-invasive ...

What is the current status of trial NCT02767726?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2016-01. Estimated completion is 2017-04.

What interventions are being tested in trial NCT02767726?

The interventions under investigation include: non-invasive multimodal imaging (DEVICE).

Who is sponsoring clinical trial NCT02767726?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02767726's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02767726, the US trial registry maintained by the National Library of Medicine. NCT02767726 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.